Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis von Hassanein, Tarek I., Tofteng, Flemming, Brown, Robert S., McGuire, Brendan, Lynch, Patrick, Mehta, Ravindra, Larsen, Fin S., Gornbein, Jeff, Stange, Jan, Blei, Andres T.

Volltext

Induction of apoptosis in human lung cancer cells by curcumin von Radhakrishna Pillai, G, Srivastava, Anand S, Hassanein, Tarek I, Chauhan, Dharam P, Carrier, Ewa

Volltext

Management of the patient with SVR von Terrault, Norah A, Hassanein, Tarek I

Volltext

Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA) von Hassanein, Tarek I., Hilsabeck, Robin C., Perry, William

Volltext

Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials von Bajaj, Jasmohan S., Hassanein, Tarek I., Pyrsopoulos, Nikolaos T., Sanyal, Arun J., Rahimi, Robert S., Heimanson, Zeev, Israel, Robert J., Rockey, Don C.

Volltext

The Molecular Adsorbents Recycling System as a Liver Support System Based on Albumin Dialysis: A Summary of Preclinical Investigations, Prospective, Randomized, Controlled Clinical... von Stange, Jan, Hassanein, Tarek I., Mehta, Ravindra, Mitzner, Steffen R., Bartlett, Robert H.

Volltext

Cognitive Dysfunction in Chronic Hepatitis C: A Review von Perry, William, Hilsabeck, Robin C., Hassanein, Tarek I.

Volltext

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis von Rezaee-Zavareh, Mohammad Saeid, Yeo, Yee Hui, Wang, Tielong, Guo, Zhiyong, Tabrizian, Parissa, Ward, Stephen C., Barakat, Fatma, Hassanein, Tarek I., Dave, Shravan, Ajmera, Veeral, Bhoori, Sherrie, Mazzaferro, Vincenzo, Chascsa, David M.H., Liu, Margaret C., Aby, Elizabeth S., Lake, John R., Sogbe, Miguel, Sangro, Bruno, Abdelrahim, Maen, Esmail, Abdullah, Schmiderer, Andreas, Chouik, Yasmina, Rudolph, Mark, Sohal, Davendra, Giudicelli, Heloise, Allaire, Manon, Akce, Mehmet, Guadagno, Jessica, Tow, Clara Y., Massoumi, Hatef, De Simone, Paolo, Kang, Elise, Gartrell, Robyn D., Martinez, Mercedes, Paz-Fumagalli, Ricardo, Toskich, Beau B., Tran, Nguyen H., Solino, Gabriela Azevedo, Poltronieri Pacheco, Dra Mariana, Kalman, Richard S., Agopian, Vatche G., Mehta, Neil, Parikh, Neehar D., Singal, Amit G., Yang, Ju Dong

Volltext

Safety, pharmacokinetics and antiviral activity of ABI‐H2158, a hepatitis B virus core inhibitor: A randomized, placebo‐controlled phase 1 study von Agarwal, Kosh, Xu, Jia, Gane, Edward J., Nguyen, Tuan T., Ding, Yanhua, Knox, Steven J., Alves, Katia, Evanchik, Marc, Zomorodi, Katie, Ma, Julie, Yan, Ran, Huang, Qi, Colonno, Richard, Stamm, Luisa M., Hassanein, Tarek I., Kim, Dong Joon, Lim, Young‐Suk, Yuen, Man‐Fung

Volltext

Neuropsychological impairment in patients with chronic hepatitis C von Hilsabeck, Robin C., Perry, William, Hassanein, Tarek I.

Volltext

Outcomes of HCV Management by Mid-Level Providers are Similar to the Outcome of Management in Clinical Trials or by Hepatologists in Difficult to Treat Patients von Barakat, Fatma, Petcharaporn, Lita, Hefner, Anna Marie, Hill, Catherine, Vawter, Beth, Butler, Elizabeth, Pozza, Renee, Gutierrez, Julio A, Hassanein, Tarek I

Volltext

Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin von Brixner, Diana I, Ye, Xin, Chu, Teng-Chiao, Blumentals, William A, Hassanein, Tarek I

Volltext

Sa1010 The Role of Transient Elastography in Assessing Significant Liver Fibrosis and Cirrhosis in Patients With Chronic Liver Disease: An Evaluation of MRE and FibroScan in Hepato... von Suliman, Idrees, Kady, Yaseen, Hassanein, Roukaya, Couturier, Thomas, Hefner, Anna Marie, Low, Russell, Hassanein, Tarek I

Volltext

Acute-on-chronic liver failure: extracorporeal liver assist devices von Hassanein, Tarek I, Schade, Robert R, Hepburn, Iryna S

Volltext

755 100% Svr4 and Favorable Safety of Abt-493 + Abt-530 Administered for 12 Weeks in Non-Cirrhotic Patients With Genotypes 4, 5, or 6 Infection (Surveyor-I) von Gane, Edward, Lalezari, Jacob, Asatryan, Armen, Greenbloom, Susan, Hassanein, Tarek I, Ng, Teresa, Liu, Ran, Lin, Chih-Wei, Kort, Jens, Mensa, Federico

Volltext

Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus–infected patients receiving ribavirin plus interferon alfa von Dieterich, Douglas T, Wasserman, Ronald, Bräu, Norbert, Hassanein, Tarek I, Bini, Edmund J, Bowers, Peter J, Sulkowski, Mark S

Volltext

Su1401 Treatment of HCV Using Combination DAAs Can Be Successfully Managed by Trained Healthcare Extenders von Hefner, Anna Marie, Suliman, Idrees, Hassanein, Roukaya, Hill, Catherine, Pozza, Renee, Couturier, Thomas, Reshamwala, Preeti A, Hassanein, Tarek I

Volltext

503 High SVR Rates in Patients with Genotype 4 Chronic Hepatitis C Infection and Compensated Cirrhosis With Ombitasvir/Paritaprevir/Ritonavir Co-Administered With Ribavirin (AGATE-... von Asselah, Tarik, Hezode, Christophe, Qaqish, Roula B, Elkhashab, Magdy, Hassanein, Tarek I, Papatheodoridis, George, Feld, Jordan, Alqahtani, Saleh, Pilot-Matias, Tami, Yu, Yao, Redman, Rebecca, Mobashery, Niloufar

Volltext

Su1427 Improvement in Markers of Liver Fibrosis and Function in HCV Genotype 4-Infected Patients With Compensated Cirrhosis Receiving Ombitasvir/Paritaprevir/Ritonavir With Ribavir... von Hassanein, Tarek I, Asselah, Tarik, Qaqish, Roula B, Hezode, Christophe, Mulkay, Jean-Pierre, Moreno, Christophe, Elkhashab, Magdy, Alqahtani, Saleh, Yu, Yao, Redman, Rebecca, Mobashery, Niloufar

Volltext

752 High SVR Rates With the Combination of ABT-493 + ABT-530 for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 1 or 2 Infection von Poordad, Fred, Felizarta, Franco, Wang, Stanley, Asatryan, Armen, Hassanein, Tarek I, Aguilar, Humberto, Lalezari, Jacob, Overcash, J. Scott, Ng, Teresa, Lovell, Sandra S, Lin, Chih-Wei, Kort, Jens, Mensa, Federico

Volltext